|4Dec 12, 7:49 PM ET

Almenoff June Sherie 4

4 · TENAX THERAPEUTICS, INC. · Filed Dec 12, 2024

Insider Transaction Report

Form 4
Period: 2024-12-10
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-10+100,000100,000 total
    Exercise: $5.94From: 2025-12-10Exp: 2034-12-10Common Stock (100,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10Common Stock (4 underlying)
    4
  • Stock Option (right to buy)

    Exercise: $992.00From: 2023-06-09Exp: 2032-06-09Common Stock (4 underlying)
    4
Footnotes (2)
  • [F1]These options were previously reported as covering 6,250 shares at an exercise price of $2.00 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
  • [F2]These options were previously reported as covering 5,000 shares at an exercise price of $0.62 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT